Extended Data Table 3 HRQOL over time, regression analysis

From: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer

  1. Results of the longitudinal linear regression modelling showing the estimates (coefficients), standard errors, degrees of freedom (df), z-values and two-sided p values for all variables in the model. aTime since randomization in days (continuous variable). Of note, all questionnaires up until a maximum of 60 days after end of SONIA treatment were included of patients who filled out at least the baseline questionnaire (no restrictions on timepoints as compared to the descriptive analysis), resulting in 869 patients contributing to 3,634 observations). ***P value ≤ 0.001.
Back to article page